Cellin Technologies is an Estonian regenerative medicine company founded in 2013, specializing in the analysis, design, and production of cell therapy products. The company's scientific foundation comprises tools and methods that facilitate the development of a deep understanding of stem cells, their biological function, and the manufacturing process.
Founded in 2008, Cellin Technologies operates within the manufacturing industry and is headquartered in Estonia. The company's last investment was a Seed Round investment on 11 November 2010, with Tera Ventures as the investors.